NHLBI Catalyze R33 — Medical Device Prototype Optimization (no clinical trials)
This NHLBI Catalyze R33 supports late-stage prototype optimization for medical devices, diagnostic assays, and research tools targeting heart, lung, blood, and sleep (HLBS) diseases; clinical trials are not allowed. Applicants must have an Accelerator Partner, provide non‑federal matching funds (recommended ≥0.25:1), submit preliminary IP and regulatory strategies, and propose milestone-driven…
Catalyze Product Definition: Medical Device Prototype Optimization
The NHLBI Catalyze program is designed to provide a suite of comprehensive support and services to facilitate the transition of basic science discoveries into new treatments for diseases and disorders that fall under the N…
Funding Source
Awards & funding
Eligibility
Foreign/Non-domestic entities are NOT eligible to apply. However, non-domestic (non-U.S.) components of U.S. organizations are eligible to apply, and foreign components (as defined in the NIH Grants Policy Statement) are allowed in awards.
Required registrations (must be completed/active …
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers